STOCKSCREENR
Log In

BDX

NYSE

Becton, Dickinson and Company

$161.64+1.37(+0.85%)Mkt Cap: $58.56B

Key Stats

Market Cap

$58.56B

P/E Ratio

26.41

EPS

$6.12

Dividend Yield

2.20%

52-Week Range

$127.59 — $187.35

Volume

2.15M

Avg Volume

2.74M

Beta

0.31

Valuation

P/E (TTM)

26.41

Forward P/E

15.43

PEG Ratio

5.21

P/S (TTM)

2.63

P/B (TTM)

1.80

P/FCF

53.54

EV/EBITDA

55.62x

EV/Sales

—

Financial Health

ROE (TTM)

0.07%

ROA (TTM)

0.03%

ROIC

0.01%

Gross Margin

0.46%

Operating Margin

0.12%

Net Margin

0.08%

Debt/Equity

0.77

Current Ratio

1.05

Growth

EPS Growth (YoY)

+0.18%

Revenue Growth (YoY)

+0.09%

EPS Growth (3Y)

+0.00%

EPS Growth (5Y)

+0.28%

Sales Growth (3Y)

+0.05%

Sales Growth (5Y)

+0.07%

EPS Est (This Year)

$10.48

EPS Est (Next Year)

$11.12

Dividends

Dividend Yield

—

Annual Dividend

$1.05

Payout Ratio

0.60%

Frequency

—

Ex-Dividend Date

2025-12-08

Cash/Share

$3.63

Analyst Consensus

3.0

Hold

1 = Strong Buy, 5 = Strong Sell

Price Target Range

$170.00$202.00$215.00
LowMedianHigh

Consensus Target: $193.80(19.9% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

362.26M

Float

361.58M

Free Float %

99.81%

Technicals

RSI (14)

65.41

SMA 20

$173.47

SMA 50

$178.34

SMA 200

$183.36

ATR (14)

5.65

Volatility (Week)

0.01%

Volatility (Month)

0.02%

Pattern

—

Performance

1 Day

-0.10%

1 Week

-4.81%

1 Month

+11.22%

3 Months

-9.72%

6 Months

-9.68%

1 Year

—

YTD

-9.47%

All-Time High

$239.24

About

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

US

Exchange

NYSE

IPO Date

1973-02-21

Employees

70000

CEO

Thomas E. Polen Jr.

Index Membership

S&P 500

Website

https://www.bd.com

Becton, Dickinson and Company (BDX) is a healthcare company in the medical - instruments & supplies industry listed on the NYSE. With a market capitalization of $58.56B, a P/E ratio of 26.41, and a dividend yield of 2.20%, BDX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare BDX against other stocks using dozens of fundamental and technical filters.

Similar Stocks

COO

The Cooper Companies, Inc.

$72.05

+1.42%

$14.06B

ALC

Alcon Inc.

$77.78

-0.01%

$37.91B

RMD

ResMed Inc.

$233.50

+1.25%

$34.08B

WST

West Pharmaceutical Services, Inc.

$239.42

-0.37%

$17.24B

ISRG

Intuitive Surgical, Inc.

$482.76

-0.14%

$171.44B

MDLN

Medline Inc.

$42.16

+0.98%

$34.22B

Frequently Asked Questions

What is Becton, Dickinson and Company's P/E ratio?

Becton, Dickinson and Company (BDX) has a trailing twelve-month (TTM) P/E ratio of 26.41. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Becton, Dickinson and Company pay a dividend?

No, Becton, Dickinson and Company (BDX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Becton, Dickinson and Company's market cap?

Becton, Dickinson and Company (BDX) has a market capitalization of $58.56 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

What do analysts think about BDX?

Wall Street analysts have a consensus "Hold" rating on Becton, Dickinson and Company (BDX) with an average score of 3.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $193.80 implies 19.9% upside from the current price.

How has BDX performed this year?

Becton, Dickinson and Company (BDX) has returned -9.47% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.